With the advancement of the electronics industry, many medical devices that rely on some form of electric power may be adapted to contain most, if not all, of the required components within the medical device. More specifically, some medical devices may be adapted to use an internal or attachable power source instead of requiring the device to be plugged into an external power source by a cable. Merely exemplary devices that may be adapted to include a portable power source are disclosed in U.S. Pat. No. 6,500,176 entitled “Electrosurgical Systems and Techniques for Sealing Tissue,” issued Dec. 31, 2002, the disclosure of which is incorporated by reference herein; U.S. Pat. No. 7,416,101 entitled “Motor-Driven Surgical Cutting and Fastening Instrument with Loading Force Feedback,” issued Aug. 26, 2008, the disclosure of which is incorporated by reference herein; U.S. Pat. No. 7,738,971 entitled “Post-Sterilization Programming of Surgical Instruments,” issued Jun. 15, 2010, the disclosure of which is incorporated by reference herein; U.S. Pub. No. 2006/0079874 entitled “Tissue Pad for Use with an Ultrasonic Surgical Instrument,” published Apr. 13, 2006, now abandoned, the disclosure of which is incorporated by reference herein; U.S. Pub. No. 2007/0191713 entitled “Ultrasonic Device for Cutting and Coagulating,” published Aug. 16, 2007, the disclosure of which is incorporated by reference herein; U.S. Pub. No. 2007/0282333 entitled “Ultrasonic Waveguide and Blade,” published Dec. 6, 2007, now abandoned, the disclosure of which is incorporated by reference herein; U.S. Pub. No. 2008/0200940 entitled “Ultrasonic Device for Cutting and Coagulating,” published Aug. 21, 2008, now abandoned, the disclosure of which is incorporated by reference herein; U.S. Pub. No. 2009/0209990 entitled “Motorized Surgical Cutting and Fastening Instrument Having Handle Based Power Source,” published Aug. 20, 2009, (now U.S. Pat. No. 8,657,174, issued Feb. 25, 2014), the disclosure of which is incorporated by reference herein; and U.S. Pub. No. 2010/0069940 entitled “Ultrasonic Device for Fingertip Control,” published Mar. 18, 2010, (now U.S. Pat. No. 9,023,071, issued May 5, 2015), the disclosure of which is incorporated by reference herein. Similarly, various ways in which medical devices may be adapted to include a portable power source are disclosed in U.S. Provisional Application Ser. No. 61/410,603, filed Nov. 5, 2010, entitled “Energy-Based Surgical Instruments,” the disclosure of which is incorporated by reference herein.
Electrically powered medical devices such as those referred to herein may require an internal or otherwise integral power source (e.g., a battery or battery pack, etc.) to be charged or recharged immediately before use, during use, or otherwise. In some settings (e.g., those where a charging device is re-used several times, etc.), it may be desirable to provide some degree of isolation between a charging device and the medical device to thereby reduce the likelihood that the charging device will contaminate the medical device and/or to reduce the likelihood that the medical device will contaminate the charging device. Similarly, it may be desirable to facilitate charging or recharging of the power source within relatively close proximity to the location at which the medical device will be used in a medical procedure (e.g., within an operating room, etc.). While several systems and methods have been made and used to charge or recharge power sources, it is believed that no one prior to the inventors has made or used the invention described in the appended claims.
While the specification concludes with claims which particularly point out and distinctly claim this technology, it is believed this technology will be better understood from the following description of certain examples taken in conjunction with the accompanying drawings, in which like reference numerals identify the same elements and in which:
The drawings are not intended to be limiting in any way, and it is contemplated that various embodiments of the technology may be carried out in a variety of other ways, including those not necessarily depicted in the drawings. The accompanying drawings incorporated in and forming a part of the specification illustrate several aspects of the present technology, and together with the description serve to explain the principles of the technology; it being understood, however, that this technology is not limited to the precise arrangements shown.
The following description of certain examples of the technology should not be used to limit its scope. Other examples, features, aspects, embodiments, and advantages of the technology will become apparent to those skilled in the art from the following description, which is by way of illustration, one of the best modes contemplated for carrying out the technology. As will be realized, the technology described herein is capable of other different and obvious aspects, all without departing from the technology. Accordingly, the drawings and descriptions should be regarded as illustrative in nature and not restrictive.
End effector (16) is coupled to control module (12) by another electrical connection (22). End effector (16) is configured to perform a desired function of medical device (10). By way of example only, such function may include cauterizing tissue, ablating tissue, severing tissue, ultrasonically vibrating, stapling tissue, or any other desired task for medical device (10). End effector (16) may thus include an active feature such as an ultrasonic blade, a pair of clamping jaws, a sharp knife, a staple driving assembly, a monopolar RF electrode, a pair of bipolar RF electrodes, a thermal heating element, and/or various other components. End effector (16) may also be removable from medical device (10) for servicing, testing, replacement, or any other purpose as will be apparent to one of ordinary skill in the art in view of the teachings herein. In some versions, end effector (16) is modular such that medical device (10) may be used with different kinds of end effectors (e.g., as taught in U.S. Provisional Application Ser. No. 61/410,603, etc.). Various other configurations of end effector (16) may be provided for a variety of different functions depending upon the purpose of medical device (10) as will be apparent to those of ordinary skill in the art in view of the teachings herein. Similarly, other types of components of a medical device (10) that may receive power from power source (14) will be apparent to those of ordinary skill in the art in view of the teachings herein.
Medical device (10) of the present example includes a trigger (18) and a sensor (20), though it should be understood that such components are merely optional. Trigger (18) is coupled to control module (12) and power source (14) by electrical connection (22). Trigger (18) may be configured to selectively provide power from power source (14) to end effector (16) (and/or to some other component of medical device (10)) to activate medical device (10) when performing a procedure. Sensor (20) is also coupled to control module (12) by an electrical connection (22) and may be configured to provide a variety of information to control module (12) during a procedure. By way of example only, such configurations may include sensing a temperature at end effector (16) or determining the oscillation rate of end effector (16). Data from sensor (20) may be processed by control module (12) to effect the delivery of power to end effector (16) (e.g., in a feedback loop, etc.). Various other configurations of sensor (20) may be provided depending upon the purpose of medical device (10) as will be apparent to those of ordinary skill in the art in view of the teachings herein. Of course, as with other components described herein, medical device (10) may have more than one sensor (20), or sensor (20) may simply be omitted if desired.
It should also be understood that control module (120) may be removed for servicing, testing, replacement, or any other purpose as will be apparent to one of ordinary skill in the art in view of the teachings herein. Further, end effector (140) may also be removable from medical device (100) for servicing, testing, replacement, or any other purpose as will be apparent to one of ordinary skill in the art in view of the teachings herein. While certain configurations of an exemplary medical device (100) have been described, various other ways in which medical device (100) may be configured will be apparent to those of ordinary skill in the art in view of the teachings herein. By way of example only, medical devices (10, 100) and/or any other medical device referred to herein may be constructed in accordance with at least some of the teachings of U.S. Pat. Nos. 6,500,176; 7,416,101; 7,738,971; U.S. Pub. No. 2006/0079874, now abandoned; U.S. Pub. No. 2007/0191713, now abandoned; U.S. Pub. No. 2007/0282333, now abandoned; U.S. Pub. No. 2008/0200940, now abandoned; U.S. Pub. No. 2009/0209990 (now U.S. Pat. No. 8,657,174); U.S. Pub. No. 2010/0069940 (now U.S. Pat. No. 9,023,071); and/or U.S. Provisional Application Ser. No. 61/410,603.
It is further understood that any one or more of the teachings, expressions, embodiments, examples, etc. described herein may be combined with any one or more of the other teachings, expressions, embodiments, examples, etc. that are described herein. The following-described teachings, expressions, embodiments, examples, etc. should therefore not be viewed in isolation relative to each other. Various suitable ways in which the teachings herein may be combined will be readily apparent to those of ordinary skill in the art in view of the teachings herein. Such modifications and variations are intended to be included within the scope of the claims.
It should also be understood that various teachings herein may be readily combined with various teachings in any of the following patent applications, all of which are filed on even date herewith and the disclosures of all of which are incorporated by reference herein: U.S. patent application Ser. No. 13/151,471, entitled “Medical Device Packaging with Charging Interface,” published May 10, 2012 as U.S. Pub. No. 2012/0112690, issued as U.S. Pat. No. 9,000,720 on Apr. 7, 2015; U.S. patent application Ser. No. 13/151,481, entitled “Motor Driven Electrosurgical Device with Mechanical and Electrical Feedback,” issued as U.S. Pat. No. 9,161,803 on Oct. 20, 2015; U.S. patent application Ser. No. 13/151,488, entitled “Packaging for Reclaimable Component of a Medical Device,” published May 10, 2012 as U.S. Pub. No. 2012/0111591, now abandoned; U.S. patent application Ser. No. 13/151,498, entitled “Sterile Housing for Non-Sterile Medical Device Component,” issued a U.S. Pat. No. 9,017,851 on Apr. 28, 2015; U.S. patent application Ser. No. 13/151,509, entitled “Medical Device Packaging with Window for Insertion of Reusable Component,” issued as U.S. Pat. No. 9,089,338 on Jul. 28, 2015; U.S. patent application Ser. No. 13/151,512, entitled “Medical Device with Feature for Sterile Acceptance of Non-Sterile Reusable Component,” issued as U.S. Pat. No. 9,072,523 on Jul. 7, 2015; and U.S. patent application Ser. No. 13/151,515, entitled “Sterile Package System for Medical Device,” issued as U.S. Pat. No. 10,080,813 on Sep. 25, 2018. Various suitable ways in which teachings herein may be combined with teachings of the above-referenced patent applications, as well as various ways in which teachings of the above-referenced patent applications may be combined together with or without teachings herein, will be apparent to those of ordinary skill in the art.
In the present example, integral power source (218) includes a single battery. In particular, integral power source (218) in this example provides enough power in a single charge to activate end effector (212) one or more times during a normal use of medical device (200) in a medical procedure. However, integral power source (218) in this example does not necessarily provide enough power to activate end effector (212) as many times as needed during a normal use of medical device (200) in a medical procedure without providing at least some degree of recharging of integral power source (218). To that end, a relatively thin charging wire (230) is coupled with handpiece (210) at coupling (220). Charging wire (230) is also coupled with an adapter (232), which is further coupled with a conventional power cable (234). Power cable (234) is plugged into a conventional wall outlet (236), though it should be understood that charging wire (230), adapter (232), and/or power cable (234) may alternatively be coupled with a piece of capital equipment and/or some other component.
Charging wire (230) is operable to deliver enough power to integral power source (218) to sufficiently charge integral power source (218) during a normal use of medical device (200) in a medical procedure. However, in the present example, charging wire (230) does not have sufficient thickness to provide all power needed to activate end effector (212) during normal use of medical device (200) in a medical procedure. Thus, charging wire (230) and integral power source (218) work in tandem—with integral power source (218) being the primary power source for end effector (212) and with charging wire (230) being used to recharge integral power source (218) (e.g., between selective activations of end effector (212), etc.).
Charging wire (230) of the present example is also substantially thinner than conventional power cable (234). It should be understood that this may provide greater mobility for medical device (200) due to reduced weight pulling on handpiece (210), particularly if adapter (232) and cable (234) rest on the floor. As is also shown in
In some versions, using a single battery for integral power source (218) may help reduce the overall cost and weight of medical device (200). In other words, using a larger integral power source (218) that is capable of activating end effector (212) enough times during normal use of medical device (200) without such a power source (218) having to be recharged might result in a more expensive and/or heavier medical device (200). Of course, integral power source (218) may comprise more than one battery or may even comprise some kind of power source other than a battery. Furthermore, integral power source (218) may be configured to hold enough charge sufficient to activate end effector (212) enough times during normal use of medical device (200) without such a power source (218) having to be recharged.
In some instances, a surgeon may wish to decouple wire (230) from handpiece (210) to provide greater mobility or positioning of medical device (200). In such instances, wire (230) may be readily re-coupled with handpiece (210) at coupling (220), even in the operating room, to provide any additional charge that may be needed for integral power source (218) after one or more activations of end effector (212). Furthermore, handpiece (210) or some other component of medical device (200) may include a charge indicator, providing a visual and/or audio indication of the charge state of power source (218), thereby alerting the surgeon to when power source (218) needs to be recharged. Still other suitable components, features, configurations, and operabilities of medical device (200) will be apparent to those of ordinary skill in the art in view of the teachings herein.
Medical device (310) of the present example includes a handpiece (312), an end effector (314) disposed at the distal end of a shaft (316), and a trigger (318). As shown in
Once coupled with handpiece (312), battery (320) and control module (330) cooperate to selectively activate end effector (314) in accordance with actuations of trigger (318). As also shown in
By way of example only, end effector (314) may comprise a harmonic blade, a pair of clamping jaws, and/or one or more electrosurgical elements. It should be understood that medical device (310) may be constructed and operable in accordance with medical device (10, 100) and/or in accordance with at least some of the teachings of any of the references cited herein. Various other kinds of devices to which the teachings of medical device (310) may be applied will be apparent to those of ordinary skill in the art in view of the teachings herein.
As best seen in
Handpiece (312) of the present example also includes a component ejection feature (380), which includes a button and a spring-loaded release mechanism. As shown in
As another merely illustrative example, it may be desirable in some instances to separately collect batteries (320) and/or control module (330) for reclamation (e.g., cleaning and re-sterilization, etc.) and re-use. For instance, this may be desirable where battery (320) and/or control module (330) are relatively high cost items; and/or to again avoid environmental concerns that might be associated with simple disposal of battery (320) and/or control module (330). As shown in
In some versions, control module (330) is not removable from medical device (310), such that only battery (320) is removable from medical device (310). Similarly, in some versions control module (330) is removable from medical device (310) and either battery (320) is non-removable or medical device (310) receives power from some other source. It should also be understood that charger (324) or some other feature of kit (300) may be configured to safely discharge batteries (320) before batteries (320) are disposed of or sent off for reclamation/processing in reclamation bag (340). Still other suitable components, features, configurations, and operabilities of kit (300) will be apparent to those of ordinary skill in the art in view of the teachings herein.
As noted above, in medical devices having internal power sources such as batteries, etc., it may be necessary to charge or recharge such internal power sources before and/or during use of the medical device in a medical procedure. In some instances, this may require physically coupling (e.g., via contact) a component of the medical device with a component of a docking station or other type of charging device. In some settings, such physical contact may present concerns as to sterility. In particular, such as situations where the docking station or other charging device is re-used, it may be desirable in some instances to provide ready re-use of such a docking station or other charging device without necessarily having to fully re-sterilize the docking station or other charging device between uses. Thus, in some situations where the docking station or other charging device is not sterile, it may be desirable to prevent such non-sterility from contaminating a sterile medical device when some degree of contact is required between the docking station or other charging device and the medical device in order to charge/recharge the medical device. The following examples present ways in which a non-sterile charging device may be used to charge a sterile medical device without compromising the sterility of the medical device despite some degree of contact with the medical device. Further examples and variations will be apparent to those of ordinary skill in the art in view of the teachings herein.
A. Exemplary Charging Station with Sterile Barrier
Base (410) includes a power cord (412) that is configured to plug into a conventional wall outlet or a piece of capital equipment. A pair of spike contacts (414) protrude upwardly from base (410). While spike contacts (414) have a sharp conical shape in the present example, it should be understood that contacts (414) may have any other suitable shape. Contacts (462) of handpiece (450) are configured to receive spike contacts (414) when handpiece is coupled with charging station (400), such that spike contacts (414) are operable to charge power source (460). Collar (430) is configured to insertingly receive a lower portion of handpiece (450) and is configured to provide structural support to handpiece (450). In particular, collar (430) has angled sidewalls (432) providing a tapered configuration, which helps prevent handpiece (450) and collar (430) from tipping over. While contacts (414) are shown protruding upwardly from base (410), it should be understood that the contacts (414) could alternatively reside and point downwardly from within handpiece (450) and make contact with contacts of base (410).
Film (420) comprises a sterile sheet of plastic film, and is configured to provide a sterile barrier between the exterior of sterile handpiece (450) and non-sterile base (410). In particular, film (420) is interposed between handpiece (450) and base (410). In the present example, collar (430) is also sterile, and is also positioned above film (420). It should be understood, however, that film (420) may optionally be draped over collar (430), and that film (420) may deform when handpiece (450) is inserted in collar (430), such that film (420) may serve as a sterile barrier between the sterile exterior of handpiece (450) and a non-sterile collar (430). As best seen in
In some versions, spike contacts (414) are selectively retractable within base (410). For instance, spike contacts (414) may be retracted in base (410) as charging station (400) is being prepared for use, as shown in
In some other versions, spike contacts (414) are integral features of collar (430) instead of being integral features of base (410). For instance, base (410) may present a pair of contacts that mate with complementary contacts on the underside of collar (430), through openings (422) in film (420). Such contacts on the underside of collar (430) may be in communication with spike contacts (414). Still other suitable components, features, configurations, and operabilities of charging station (400) will be apparent to those of ordinary skill in the art in view of the teachings herein.
B. Exemplary Charging Station with Breakaway Prongs
Base (510) of the present example includes a cable (not shown) that is configured to plug into a conventional wall outlet or piece of capital equipment, etc., to deliver a charge to power source (560) as described in greater detail below. Retention pins (514) are configured to move toward a central member (516) within recess (512) when prongs (562) are sufficiently positioned within recess (512). By way of example only, base (510) may include a spring-loaded trip mechanism that is responsive to insertion of prongs (562) in recess, and such a trip mechanism may cause pins (514) to move toward central member (516) as shown in
As can also be seen in
In an exemplary use, a user initially positions handpiece (550) over base (510) as shown in
In some versions, handpiece (550) includes a door, cap, or other feature that is operable to close off sockets (564) when prongs (562) are pulled free from sockets (564), thereby effectively sealing off the bottom of handpiece (550). Such a feature may be manually operated after handpiece (550) is pulled away from base (510). Alternatively, a mechanism may automatically case such a feature to be released to close off sockets (564) when prongs (562) are pulled free from sockets (564). Various suitable ways in which such a feature may be provided will be apparent to those of ordinary skill in the art in view of the teachings herein. Similarly, various other suitable components, features, configurations, and operabilities of charging station (500) and handpiece (550) will be apparent to those of ordinary skill in the art in view of the teachings herein.
The examples described above with reference to
A. Exemplary Charging Pad with Wireless Communication of Charge State
Medical device (650) of this example includes an integral power source (660), which includes a secondary inductive coil (662), a control module (664), and at least one battery (666). As with other control modules referred to herein, control module (664) may include a variety of components, including but not limited to a printed circuit board, a microprocessor, a memory device, etc. Various suitable components, features, and configurations for the various control modules referred to herein will be apparent to those of ordinary skill in the art in view of the teachings herein. Medical device (650) also includes a charge indicator (656) in this example, though it should be understood that in other versions either or both of charge indicators (606, 656) may be omitted. It should also be understood that medical device (650) may be constructed and operable in accordance with medical device (10, 100) and/or in accordance with at least some of the teachings of any of the references cited herein. For instance, medical device (650) may include an ultrasonic or electrosurgical end effector (not shown) that is selectively activated by power source (660). Various other types of forms that medical device (650) may take will be apparent to those of ordinary skill in the art in view of the teachings herein.
With power cable (608) plugged in, and when medical device (650) is brought within sufficient proximity of charging pad (600), coils (602, 662) inductively couple, thereby forming a transformer and allowing the wireless transfer of energy from coil (602) to coil (662), thereby charging battery (666) through induction of a current in coil (662). Control module (664) is operable to monitor the charge level of battery (666) in real time. Control module (664) is further operable to drive charge indicator (656) to indicate the charge level of battery (666) (e.g., visually and/or audibly) in real time. In addition, control module (664) is operable to communicate the charge level of battery (666) back to control module (664) via coils (662, 602). For instance, control module (664) may superimpose a data carrier on the charging waveform through modulation, allowing such data to be communicated form coil (662) to coil (602). Control module (604) may receive such data via coil (602) and react to it in various ways. For instance, control module (604) may drive charge indicator (606) to indicate the charge level of battery (666) (e.g., visually and/or audibly) in real time. In addition, control module (604) may adjust the charging current provided through coils (602, 662), based at least in part on the charge level of battery (666). Control modules (604, 664) may thus together provide a feedback loop, allowing the charging profile of battery (666) (e.g., frequency and/or other parameters) to be optimized in real time for whichever battery (666) is coupled with charging pad (600). Various suitable ways in which such communication between control modules (602, 664) and corresponding real time adjustments may be provided will be apparent to those of ordinary skill in the art in view of the teachings herein.
In some versions, the electronics in charging pad (600) may be encapsulated in a potting compound and/or be otherwise encapsulated. Such encapsulation may enable charging pad (600) to be sterilized using steam and/or other sterilization techniques that might otherwise not be available without damaging charging pad (600). Of course, charging pad (600) may be sterilized using a variety of other techniques, including but not limited to electron beam sterilization.
In some settings, it may be desirable to maximize the interface area of an inductive charging pad to maximize the amount of current that may be transferred to a battery pack or other type of power source. To that end,
B. Exemplary Charging Pad on Stand with Sterile Drape
As noted above, an inductive charging pad may be sterilized using steam, electron beam sterilization, and/or using other sterilization techniques. It should also be understood, however, that an inductive charging pad may still be used, even in an operating room, without the charging pad necessarily being sterilized, and without the non-sterile charging pad compromising the sterility of the medical device that it charges. For instance, as shown in
C. Exemplary Charging Peg on Stand with Sterile Drape
Charging device (900) of this example is configured for use with a medical device having a handpiece (950) as shown in
As with charging pad (800), charging device (950) may be used in an operating room without being sterile and without compromising the sterility of handpiece (950) or other items in the operating room. In other words, even if charging device (900) is non-sterile, power source (954) may be charged by charging device (900) through sterile drape (940), and sterile drape (940) may help maintain the sterility of handpiece (950) by preventing contamination from non-sterile charging device (900). The medical device having handpiece (950) may be constructed and operable in accordance with medical device (10, 100) and/or in accordance with at least some of the teachings of any of the references cited herein. Various other types of devices that may include handpiece (950) will be apparent to those of ordinary skill in the art in view of the teachings herein. Similarly, various other suitable forms that charging device (900) may take will be apparent to those of ordinary skill in the art in view of the teachings herein.
While several of the examples described above have included batteries as a primary integral source of power in a medical device, it should be understood that other types of components may provide a primary integral source of power in a medical device. For instance,
It should be appreciated that any patent, publication, or other disclosure material, in whole or in part, that is said to be incorporated by reference herein is incorporated herein only to the extent that the incorporated material does not conflict with existing definitions, statements, or other disclosure material set forth in this disclosure. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.
Embodiments of the present invention have application in conventional endoscopic and open surgical instrumentation as well as application in robotic-assisted surgery.
Embodiments of the devices disclosed herein can be designed to be disposed of after a single use, or they can be designed to be used multiple times. Embodiments may, in either or both cases, be reconditioned for reuse after at least one use. Reconditioning may include any combination of the steps of disassembly of the device, followed by cleaning or replacement of particular pieces, and subsequent reassembly. In particular, embodiments of the device may be disassembled, and any number of the particular pieces or parts of the device may be selectively replaced or removed in any combination. Upon cleaning and/or replacement of particular parts, embodiments of the device may be reassembled for subsequent use either at a reconditioning facility, or by a surgical team immediately prior to a surgical procedure. Those skilled in the art will appreciate that reconditioning of a device may utilize a variety of techniques for disassembly, cleaning/replacement, and reassembly. Use of such techniques, and the resulting reconditioned device, are all within the scope of the present application.
By way of example only, embodiments described herein may be processed before surgery. First, a new or used instrument may be obtained and if necessary cleaned. The instrument may then be sterilized. In one sterilization technique, the instrument is placed in a closed and sealed container, such as a plastic or TYVEK bag. The container and instrument may then be placed in a field of radiation that can penetrate the container, such as gamma radiation, x-rays, or high-energy electrons. The radiation may kill bacteria on the instrument and in the container. The sterilized instrument may then be stored in the sterile container. The sealed container may keep the instrument sterile until it is opened in a medical facility. A device may also be sterilized using any other technique known in the art, including but not limited to beta or gamma radiation, ethylene oxide, or steam.
Having shown and described various embodiments of the present invention, further adaptations of the methods and systems described herein may be accomplished by appropriate modifications by one of ordinary skill in the art without departing from the scope of the present invention. Several of such potential modifications have been mentioned, and others will be apparent to those skilled in the art. For instance, the examples, embodiments, geometrics, materials, dimensions, ratios, steps, and the like discussed above are illustrative and are not required. Accordingly, the scope of the present invention should be considered in terms of the following claims and is understood not to be limited to the details of structure and operation shown and described in the specification and drawings.
This application is a continuation of U.S. patent application Ser. No. 15/212,423, entitled “Sterile Medical Instrument Charging Device,” filed on Jul. 18, 2016, published as U.S. Pub. No. 2016/0329614 on Nov. 10, 2016, issued as U.S. Pat. No. 10,660,695 on May 26, 2020, which is a continuation of U.S. patent application Ser. No. 13/151,503, entitled “Sterile Medical Instrument Charging Device,” filed on Jun. 2, 2011, issued as U.S. Pat. No. 9,597,143 on Mar. 21, 2017. U.S. patent application Ser. No. 13/151,503, filed on Jul. 2, 2011, issued as U.S. Pat. No. 9,597,143 on Mar. 21, 2017, claims priority to U.S. Provisional Application Ser. No. 61/410,603, filed Nov. 5, 2010, entitled “Energy-Based Surgical Instruments,” the disclosure of which is incorporated by reference herein. U.S. patent application Ser. No. 13/151,503, Jul. 2, 2011, issued as U.S. Pat. No. 9,597,143 on Mar. 21, 2017, also claims priority to U.S. Provisional Application Ser. No. 61/487,846, filed May 19, 2011, entitled “Energy-Based Surgical Instruments,” the disclosure of which is incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
1754806 | Stevenson | Apr 1930 | A |
3297192 | Swett | Jan 1967 | A |
3419198 | Pettersen | Dec 1968 | A |
3619671 | Shoh | Nov 1971 | A |
4034762 | Cosens et al. | Jul 1977 | A |
4057220 | Kudlacek | Nov 1977 | A |
4535773 | Yoon | Aug 1985 | A |
4641076 | Linden et al. | Feb 1987 | A |
4641077 | Pascaloff | Feb 1987 | A |
4662068 | Polonsky | May 1987 | A |
4666037 | Weissman | May 1987 | A |
4685459 | Koch et al. | Aug 1987 | A |
4717018 | Sacherer et al. | Jan 1988 | A |
4717050 | Wright | Jan 1988 | A |
4721097 | D'Amelio | Jan 1988 | A |
4768969 | Bauer et al. | Sep 1988 | A |
4800878 | Cartmell | Jan 1989 | A |
4844259 | Glowczewskie, Jr. et al. | Jul 1989 | A |
4878493 | Pasternak et al. | Nov 1989 | A |
5071417 | Sinofsky | Dec 1991 | A |
5107155 | Yamaguchi | Apr 1992 | A |
5144771 | Miwa | Sep 1992 | A |
5169733 | Savovic et al. | Dec 1992 | A |
5176677 | Wuchinich | Jan 1993 | A |
5246109 | Markle et al. | Sep 1993 | A |
5273177 | Campbell | Dec 1993 | A |
5277694 | Leysieffer et al. | Jan 1994 | A |
5308358 | Bond et al. | May 1994 | A |
5322055 | Davison et al. | Jun 1994 | A |
5339799 | Kami et al. | Aug 1994 | A |
5357732 | Markle et al. | Oct 1994 | A |
5358508 | Cobb et al. | Oct 1994 | A |
5361902 | Abidin et al. | Nov 1994 | A |
5429229 | Chester et al. | Jul 1995 | A |
5449370 | Vaitekunas | Sep 1995 | A |
5452391 | Chou et al. | Sep 1995 | A |
5454378 | Palmer et al. | Oct 1995 | A |
5501607 | Yoshioka et al. | Mar 1996 | A |
5507297 | Slater et al. | Apr 1996 | A |
5561881 | Klinger et al. | Oct 1996 | A |
5578052 | Koros et al. | Nov 1996 | A |
5580258 | Wakata | Dec 1996 | A |
5582617 | Klieman et al. | Dec 1996 | A |
5590778 | Dutchik | Jan 1997 | A |
5592065 | Oglesbee et al. | Jan 1997 | A |
5597371 | Liberti et al. | Jan 1997 | A |
5599350 | Schulze et al. | Feb 1997 | A |
5630420 | Vaitekunas | May 1997 | A |
5630456 | Hugo et al. | May 1997 | A |
5690222 | Peters | Nov 1997 | A |
5707369 | Vaitekunas et al. | Jan 1998 | A |
5741305 | Vincent et al. | Apr 1998 | A |
5776155 | Beaupre et al. | Jul 1998 | A |
5800336 | Ball et al. | Sep 1998 | A |
5817128 | Storz | Oct 1998 | A |
5868244 | Ivanov et al. | Feb 1999 | A |
5873873 | Smith et al. | Feb 1999 | A |
5882310 | Marian, Jr. | Mar 1999 | A |
5893835 | Witt et al. | Apr 1999 | A |
5935144 | Estabrook | Aug 1999 | A |
5938633 | Beaupre | Aug 1999 | A |
5944737 | Tsonton et al. | Aug 1999 | A |
5951575 | Bolduc et al. | Sep 1999 | A |
5980510 | Tsonton et al. | Nov 1999 | A |
5997531 | Loeb et al. | Dec 1999 | A |
6018227 | Kumar et al. | Jan 2000 | A |
6051010 | Dimatteo et al. | Apr 2000 | A |
6056735 | Okada et al. | May 2000 | A |
6063098 | Houser et al. | May 2000 | A |
6066151 | Miyawaki et al. | May 2000 | A |
6083191 | Rose | Jul 2000 | A |
6083223 | Baker | Jul 2000 | A |
6099537 | Sugai et al. | Aug 2000 | A |
6113593 | Tu et al. | Sep 2000 | A |
6113596 | Hooven et al. | Sep 2000 | A |
6123702 | Swanson et al. | Sep 2000 | A |
6165191 | Shibata et al. | Dec 2000 | A |
6190386 | Rydell | Feb 2001 | B1 |
6204592 | Hur | Mar 2001 | B1 |
6214023 | Whipple et al. | Apr 2001 | B1 |
6246896 | Dumoulin et al. | Jun 2001 | B1 |
6248238 | Burtin et al. | Jun 2001 | B1 |
6287304 | Eggers et al. | Sep 2001 | B1 |
6325811 | Messerly | Dec 2001 | B1 |
6339368 | Leith | Jan 2002 | B1 |
6398755 | Belef et al. | Jun 2002 | B1 |
6409742 | Fulton, III et al. | Jun 2002 | B1 |
6500176 | Truckai et al. | Dec 2002 | B1 |
6500188 | Harper et al. | Dec 2002 | B2 |
6512667 | Shiue et al. | Jan 2003 | B2 |
6514267 | Jewett | Feb 2003 | B2 |
6517561 | Phillips | Feb 2003 | B1 |
6520185 | Bommannan et al. | Feb 2003 | B1 |
6561983 | Cronin et al. | May 2003 | B2 |
6562032 | Ellman et al. | May 2003 | B1 |
6609414 | Mayer et al. | Aug 2003 | B2 |
6622731 | Daniel et al. | Sep 2003 | B2 |
6623500 | Cook et al. | Sep 2003 | B1 |
6626901 | Treat et al. | Sep 2003 | B1 |
6647281 | Morency | Nov 2003 | B2 |
6650091 | Shiue et al. | Nov 2003 | B1 |
6650975 | Ruffner | Nov 2003 | B2 |
6656177 | Truckai et al. | Dec 2003 | B2 |
6658301 | Loeb et al. | Dec 2003 | B2 |
6666875 | Sakurai et al. | Dec 2003 | B1 |
6706038 | Francischelli et al. | Mar 2004 | B2 |
6717193 | Olewine et al. | Apr 2004 | B2 |
6730042 | Fulton et al. | May 2004 | B2 |
6753673 | Shiue et al. | Jun 2004 | B2 |
6758855 | Fulton, III et al. | Jul 2004 | B2 |
6761698 | Shibata et al. | Jul 2004 | B2 |
6761701 | Cucin | Jul 2004 | B2 |
6783524 | Anderson et al. | Aug 2004 | B2 |
6815206 | Lin et al. | Nov 2004 | B2 |
6821671 | Hinton et al. | Nov 2004 | B2 |
6836097 | Turner et al. | Dec 2004 | B2 |
6838862 | Luu | Jan 2005 | B2 |
6847192 | Turner et al. | Jan 2005 | B2 |
6860880 | Treat et al. | Mar 2005 | B2 |
6869435 | Blake | Mar 2005 | B2 |
6923807 | Ryan et al. | Aug 2005 | B2 |
6982696 | Shahoian | Jan 2006 | B1 |
6998822 | Turner et al. | Feb 2006 | B2 |
7031155 | Sauciuc et al. | Apr 2006 | B2 |
7061749 | Liu et al. | Jun 2006 | B2 |
7077853 | Kramer et al. | Jul 2006 | B2 |
7083589 | Banko et al. | Aug 2006 | B2 |
7085123 | Shiue et al. | Aug 2006 | B2 |
7101371 | Dycus et al. | Sep 2006 | B2 |
7112201 | Truckai et al. | Sep 2006 | B2 |
7125409 | Truckai et al. | Oct 2006 | B2 |
7150712 | Buehlmann et al. | Dec 2006 | B2 |
7160132 | Phillips et al. | Jan 2007 | B2 |
7169146 | Truckai et al. | Jan 2007 | B2 |
7186253 | Truckai et al. | Mar 2007 | B2 |
7186473 | Shiue et al. | Mar 2007 | B2 |
7189233 | Truckai et al. | Mar 2007 | B2 |
7220951 | Truckai et al. | May 2007 | B2 |
7221216 | Nguyen | May 2007 | B2 |
7232440 | Dumbauld et al. | Jun 2007 | B2 |
7244024 | Biscardi | Jul 2007 | B2 |
7292227 | Fukumoto et al. | Nov 2007 | B2 |
7296804 | Lechot et al. | Nov 2007 | B2 |
7303556 | Metzger et al. | Dec 2007 | B2 |
7309849 | Truckai et al. | Dec 2007 | B2 |
7311709 | Truckai et al. | Dec 2007 | B2 |
7349741 | Maltan et al. | Mar 2008 | B2 |
7353068 | Tanaka et al. | Apr 2008 | B2 |
7354440 | Truckai et al. | Apr 2008 | B2 |
7364061 | Swayze et al. | Apr 2008 | B2 |
7364554 | Bolze et al. | Apr 2008 | B2 |
7375644 | Miyazawa | May 2008 | B2 |
7381209 | Truckai et al. | Jun 2008 | B2 |
7416101 | Shelton, IV et al. | Aug 2008 | B2 |
7422139 | Shelton, IV et al. | Sep 2008 | B2 |
7464846 | Shelton, IV et al. | Dec 2008 | B2 |
7470237 | Beckman et al. | Dec 2008 | B2 |
7473145 | Her et al. | Jan 2009 | B2 |
7479152 | Fulton, III et al. | Jan 2009 | B2 |
7494492 | Da Silva et al. | Feb 2009 | B2 |
D594983 | Price et al. | Jun 2009 | S |
7560903 | Thrap | Jul 2009 | B2 |
7563142 | Wenger et al. | Jul 2009 | B1 |
7570994 | Tamura et al. | Aug 2009 | B2 |
7573151 | Acena et al. | Aug 2009 | B2 |
7583564 | Ketahara et al. | Sep 2009 | B2 |
7638958 | Philipp et al. | Dec 2009 | B2 |
7643378 | Genosar | Jan 2010 | B2 |
7658247 | Carter | Feb 2010 | B2 |
7692411 | Trainor et al. | Apr 2010 | B2 |
7699850 | Miller | Apr 2010 | B2 |
7699856 | Van Wyk et al. | Apr 2010 | B2 |
7717312 | Beetel | May 2010 | B2 |
7721936 | Shalton, IV et al. | May 2010 | B2 |
7738971 | Swayze et al. | Jun 2010 | B2 |
7761198 | Bhardwaj | Jul 2010 | B2 |
7766910 | Hixson et al. | Aug 2010 | B2 |
7766929 | Masuda | Aug 2010 | B2 |
7770722 | Donahoe et al. | Aug 2010 | B2 |
7770775 | Shelton, IV et al. | Aug 2010 | B2 |
7776037 | Odom | Aug 2010 | B2 |
7780660 | Bourne et al. | Aug 2010 | B2 |
7802121 | Zansky et al. | Sep 2010 | B1 |
7815658 | Murakami | Oct 2010 | B2 |
7845537 | Shelton, IV et al. | Dec 2010 | B2 |
7846155 | Houser et al. | Dec 2010 | B2 |
7846159 | Morrison et al. | Dec 2010 | B2 |
7889489 | Richardson et al. | Feb 2011 | B2 |
7918848 | Lau et al. | Apr 2011 | B2 |
7922063 | Zemlok et al. | Apr 2011 | B2 |
7923151 | Lam et al. | Apr 2011 | B2 |
7948208 | Partovi et al. | May 2011 | B2 |
7952322 | Partovi et al. | May 2011 | B2 |
7952873 | Glahn et al. | May 2011 | B2 |
7959050 | Smith et al. | Jun 2011 | B2 |
7977921 | Bahai et al. | Jul 2011 | B2 |
7982439 | Trainor et al. | Jul 2011 | B2 |
8038025 | Stark et al. | Oct 2011 | B2 |
8040107 | Ishii | Oct 2011 | B2 |
8052605 | Muller et al. | Nov 2011 | B2 |
8058771 | Giordano et al. | Nov 2011 | B2 |
8075530 | Taylor et al. | Dec 2011 | B2 |
8083120 | Shelton et al. | Dec 2011 | B2 |
8097011 | Hideo et al. | Jan 2012 | B2 |
8142461 | Houser et al. | Mar 2012 | B2 |
8147488 | Masuda | Apr 2012 | B2 |
8177776 | Humayun et al. | May 2012 | B2 |
8179103 | Doljack | May 2012 | B2 |
8195271 | Rahn | Jun 2012 | B2 |
8210411 | Yates et al. | Jul 2012 | B2 |
8216212 | Grant et al. | Jul 2012 | B2 |
8221418 | Prakash et al. | Jul 2012 | B2 |
8240498 | Ramsey et al. | Aug 2012 | B2 |
8246642 | Houser et al. | Aug 2012 | B2 |
8251994 | McKenna et al. | Aug 2012 | B2 |
8267094 | Danek et al. | Sep 2012 | B2 |
8277446 | Heard | Oct 2012 | B2 |
8292888 | Whitman | Oct 2012 | B2 |
8298253 | Charles | Oct 2012 | B2 |
8301262 | Mi et al. | Oct 2012 | B2 |
8323271 | Humayun et al. | Dec 2012 | B2 |
8328732 | Parihar et al. | Dec 2012 | B2 |
8328802 | Deville et al. | Dec 2012 | B2 |
8333764 | Francischelli et al. | Dec 2012 | B2 |
8336725 | Ramsey et al. | Dec 2012 | B2 |
8337097 | Cao | Dec 2012 | B2 |
8344690 | Smith et al. | Jan 2013 | B2 |
8372099 | Deville et al. | Feb 2013 | B2 |
8377059 | Deville et al. | Feb 2013 | B2 |
8400108 | Powell et al. | Mar 2013 | B2 |
8403948 | Deville et al. | Mar 2013 | B2 |
8403949 | Palmer et al. | Mar 2013 | B2 |
8403950 | Palmer et al. | Mar 2013 | B2 |
8419757 | Smith et al. | Apr 2013 | B2 |
8419758 | Smith et al. | Apr 2013 | B2 |
8425545 | Smith et al. | Apr 2013 | B2 |
8444653 | Nycz et al. | May 2013 | B2 |
8444662 | Palmer et al. | May 2013 | B2 |
8449529 | Bek et al. | May 2013 | B2 |
8459520 | Giordano et al. | Jun 2013 | B2 |
8461744 | Wiener et al. | Jun 2013 | B2 |
8487487 | Dietz et al. | Jul 2013 | B2 |
8522795 | Bouix et al. | Sep 2013 | B2 |
8550106 | Hebach et al. | Oct 2013 | B2 |
8550981 | Woodruff et al. | Oct 2013 | B2 |
8551088 | Falkenstein et al. | Oct 2013 | B2 |
8564242 | Hansford et al. | Oct 2013 | B2 |
8573461 | Shelton et al. | Nov 2013 | B2 |
8574253 | Gruber et al. | Nov 2013 | B2 |
8598852 | Gilmore | Dec 2013 | B2 |
8602287 | Laurent et al. | Dec 2013 | B2 |
8608045 | Smith et al. | Dec 2013 | B2 |
8617077 | van Groningen et al. | Dec 2013 | B2 |
8622274 | Yates et al. | Jan 2014 | B2 |
8623027 | Price et al. | Jan 2014 | B2 |
8632535 | Shelton, IV et al. | Jan 2014 | B2 |
8636736 | Yates et al. | Jan 2014 | B2 |
8641629 | Kurokawa | Feb 2014 | B2 |
8657174 | Yates et al. | Feb 2014 | B2 |
8663112 | Slayton et al. | Mar 2014 | B2 |
8733614 | Ross et al. | May 2014 | B2 |
8758342 | Bales et al. | Jun 2014 | B2 |
8784415 | Malackowski et al. | Jul 2014 | B2 |
8808319 | Houser et al. | Aug 2014 | B2 |
8834465 | Ramstein et al. | Sep 2014 | B2 |
8864761 | Johnson et al. | Oct 2014 | B2 |
8906017 | Rioux et al. | Dec 2014 | B2 |
8939974 | Boudreaux et al. | Jan 2015 | B2 |
8961441 | Cioanla et al. | Feb 2015 | B2 |
8968648 | Kaneko | Mar 2015 | B2 |
8986302 | Boudreaux et al. | Mar 2015 | B2 |
8998939 | Price et al. | Apr 2015 | B2 |
9000720 | Stulen et al. | Apr 2015 | B2 |
9011336 | Slayton et al. | Apr 2015 | B2 |
9011427 | Price et al. | Apr 2015 | B2 |
9011471 | Timm et al. | Apr 2015 | B2 |
9017849 | Stulen et al. | Apr 2015 | B2 |
9017851 | Felder et al. | Apr 2015 | B2 |
9023071 | Miller et al. | May 2015 | B2 |
9039720 | Madan | May 2015 | B2 |
9044261 | Houser | Jun 2015 | B2 |
9050098 | Deville et al. | Jun 2015 | B2 |
9050125 | Boudreaux et al. | Jun 2015 | B2 |
9060750 | Lam | Jun 2015 | B2 |
9072523 | Houser et al. | Jul 2015 | B2 |
9072543 | Miller et al. | Jul 2015 | B2 |
9078671 | Beale et al. | Jul 2015 | B2 |
9089338 | Smith et al. | Jul 2015 | B2 |
9095346 | Houser et al. | Aug 2015 | B2 |
9113903 | Unger | Aug 2015 | B2 |
9161803 | Yates et al. | Oct 2015 | B2 |
9179912 | Yates et al. | Nov 2015 | B2 |
9186046 | Ramamurthy et al. | Nov 2015 | B2 |
9186047 | Ramamurthy et al. | Nov 2015 | B2 |
9192428 | Houser et al. | Nov 2015 | B2 |
9247986 | Haberstich et al. | Feb 2016 | B2 |
9308009 | Madan et al. | Apr 2016 | B2 |
9318271 | Fletcher et al. | Apr 2016 | B2 |
9364279 | Houser et al. | Jun 2016 | B2 |
9364288 | Smith et al. | Jun 2016 | B2 |
9375255 | Houser et al. | Jun 2016 | B2 |
9381058 | Houser et al. | Jul 2016 | B2 |
9408575 | Bordoley et al. | Aug 2016 | B2 |
9820738 | Lytle et al. | Nov 2017 | B2 |
10004497 | Overmyer et al. | Jun 2018 | B2 |
10376304 | Houser et al. | Aug 2019 | B2 |
10537380 | Houser et al. | Jan 2020 | B2 |
20010032666 | Jenson et al. | Oct 2001 | A1 |
20020165577 | Witt et al. | Nov 2002 | A1 |
20030093103 | Malackowski et al. | May 2003 | A1 |
20030109802 | Laeseke et al. | Jun 2003 | A1 |
20030114851 | Truckai et al. | Jun 2003 | A1 |
20030144680 | Kellogg et al. | Jul 2003 | A1 |
20030216723 | Shinmura | Nov 2003 | A1 |
20040097911 | Murakami et al. | May 2004 | A1 |
20040116952 | Sakurai et al. | Jun 2004 | A1 |
20040133189 | Sakurai | Jul 2004 | A1 |
20040173487 | Johnson et al. | Sep 2004 | A1 |
20050021065 | Yamada et al. | Jan 2005 | A1 |
20050033195 | Fulton, III et al. | Feb 2005 | A1 |
20050171522 | Christopherson | Aug 2005 | A1 |
20050203546 | Van Wyk et al. | Sep 2005 | A1 |
20060030797 | Zhou et al. | Feb 2006 | A1 |
20060079829 | Fulton, III et al. | Apr 2006 | A1 |
20060079874 | Faller et al. | Apr 2006 | A1 |
20060079877 | Houser et al. | Apr 2006 | A1 |
20060079879 | Faller et al. | Apr 2006 | A1 |
20060253176 | Caruso et al. | Nov 2006 | A1 |
20070027447 | Theroux et al. | Feb 2007 | A1 |
20070078484 | Talarico et al. | Apr 2007 | A1 |
20070103437 | Rosenberg | May 2007 | A1 |
20070191713 | Eichmann et al. | Aug 2007 | A1 |
20070207354 | Curello et al. | Sep 2007 | A1 |
20070261978 | Sanderson | Nov 2007 | A1 |
20070265613 | Edelstein et al. | Nov 2007 | A1 |
20070265620 | Kraas et al. | Nov 2007 | A1 |
20070282333 | Fortson et al. | Dec 2007 | A1 |
20070290654 | Govari | Dec 2007 | A1 |
20080003491 | Yahnker et al. | Jan 2008 | A1 |
20080004656 | Livneh | Jan 2008 | A1 |
20080057470 | Levy et al. | Mar 2008 | A1 |
20080147058 | Horrell et al. | Jun 2008 | A1 |
20080150754 | Quendt | Jun 2008 | A1 |
20080164842 | Bergner | Jul 2008 | A1 |
20080173651 | Ping | Jul 2008 | A1 |
20080188810 | Larsen et al. | Aug 2008 | A1 |
20080200940 | Eichmann et al. | Aug 2008 | A1 |
20080228104 | Uber, II et al. | Sep 2008 | A1 |
20080255413 | Zemlok et al. | Oct 2008 | A1 |
20080281301 | Deboer et al. | Nov 2008 | A1 |
20080315829 | Jones et al. | Dec 2008 | A1 |
20090043797 | Dorie et al. | Feb 2009 | A1 |
20090076506 | Baker | Mar 2009 | A1 |
20090096430 | Van Der Linde et al. | Apr 2009 | A1 |
20090143799 | Smith et al. | Jun 2009 | A1 |
20090143800 | Deville et al. | Jun 2009 | A1 |
20090253030 | Kooij | Oct 2009 | A1 |
20090281430 | Wilder | Nov 2009 | A1 |
20100021022 | Pittel et al. | Jan 2010 | A1 |
20100030218 | Prevost | Feb 2010 | A1 |
20100060231 | Trainor et al. | Mar 2010 | A1 |
20100076455 | Birkenbach et al. | Mar 2010 | A1 |
20100106144 | Matsumura et al. | Apr 2010 | A1 |
20100106146 | Boitor et al. | Apr 2010 | A1 |
20100125172 | Jayaraj | May 2010 | A1 |
20100145146 | Melder | Jun 2010 | A1 |
20100152610 | Parihar et al. | Jun 2010 | A1 |
20100201311 | Alexander et al. | Aug 2010 | A1 |
20100249665 | Roche | Sep 2010 | A1 |
20100268221 | Beller et al. | Oct 2010 | A1 |
20100274160 | Yachi et al. | Oct 2010 | A1 |
20110009694 | Schultz et al. | Jan 2011 | A1 |
20110074336 | Miller | Mar 2011 | A1 |
20110077514 | Ulric et al. | Mar 2011 | A1 |
20110080134 | Miller | Apr 2011 | A1 |
20110121049 | Malinouskas et al. | May 2011 | A1 |
20110181238 | Soar | Jul 2011 | A1 |
20110221398 | Ferber | Sep 2011 | A1 |
20120111591 | Shelton, IV et al. | May 2012 | A1 |
20120116260 | Johnson et al. | May 2012 | A1 |
20120116261 | Mumaw et al. | May 2012 | A1 |
20120116262 | Houser et al. | May 2012 | A1 |
20120116263 | Houser et al. | May 2012 | A1 |
20120116265 | Houser et al. | May 2012 | A1 |
20120116266 | Houser et al. | May 2012 | A1 |
20120116267 | Kimball et al. | May 2012 | A1 |
20120116366 | Houser et al. | May 2012 | A1 |
20120116380 | Madan et al. | May 2012 | A1 |
20120116381 | Houser et al. | May 2012 | A1 |
20120116388 | Houser et al. | May 2012 | A1 |
20120116389 | Houser et al. | May 2012 | A1 |
20120116391 | Houser et al. | May 2012 | A1 |
20120179036 | Patrick et al. | Jul 2012 | A1 |
20120292367 | Morgan et al. | Nov 2012 | A1 |
20120305427 | Felder et al. | Dec 2012 | A1 |
20130085330 | Ramamurthy et al. | Apr 2013 | A1 |
20130085332 | Ramamurthy et al. | Apr 2013 | A1 |
20130085397 | Ramamurthy et al. | Apr 2013 | A1 |
20130090528 | Ramamurthy et al. | Apr 2013 | A1 |
20130090552 | Ramamurthy et al. | Apr 2013 | A1 |
20130090675 | Mumaw et al. | Apr 2013 | A1 |
20130118733 | Kumar | May 2013 | A1 |
20140088739 | Ellis et al. | Mar 2014 | A1 |
20150305763 | Houser et al. | Oct 2015 | A1 |
20160121143 | Mumaw et al. | May 2016 | A1 |
20160206900 | Haberstich et al. | Jul 2016 | A1 |
20160329614 | Madan et al. | Nov 2016 | A1 |
20160338760 | Houser et al. | Nov 2016 | A1 |
20170245913 | Houser et al. | Aug 2017 | A1 |
20180055559 | Shelton, IV et al. | Mar 2018 | A1 |
Number | Date | Country |
---|---|---|
101683281 | Mar 2010 | CN |
101819334 | Apr 2013 | CN |
102008051866 | Oct 2010 | DE |
102009013034 | Oct 2010 | DE |
0897696 | Feb 1999 | EP |
0947167 | Oct 1999 | EP |
1330991 | Jul 2003 | EP |
1525853 | Apr 2005 | EP |
1535585 | Jun 2005 | EP |
1684396 | Jul 2006 | EP |
1721576 | Nov 2006 | EP |
1743592 | Jan 2007 | EP |
1818021 | Aug 2007 | EP |
1839599 | Oct 2007 | EP |
1868275 | Dec 2007 | EP |
1886637 | Feb 2008 | EP |
1943976 | Jul 2008 | EP |
1970014 | Sep 2008 | EP |
1997439 | Dec 2008 | EP |
2027819 | Feb 2009 | EP |
2090256 | Aug 2009 | EP |
2105104 | Sep 2009 | EP |
2165660 | Mar 2010 | EP |
2218409 | Aug 2010 | EP |
2243439 | Oct 2010 | EP |
2345454 | Jul 2011 | EP |
2425874 | Nov 2006 | GB |
2440566 | Feb 2008 | GB |
H 01-268370 | Oct 1989 | JP |
H 10-308907 | Nov 1998 | JP |
2002-336265 | Nov 2002 | JP |
2005-033868 | Feb 2005 | JP |
2010-518978 | Jun 2010 | JP |
5410110 | Feb 2014 | JP |
WO 1997024072 | Jul 1997 | WO |
WO 2000065682 | Feb 2000 | WO |
WO 2003013374 | Feb 2003 | WO |
WO 2003020139 | Mar 2003 | WO |
WO 2004113991 | Dec 2004 | WO |
WO 2005079915 | Sep 2005 | WO |
WO 2006023266 | Mar 2006 | WO |
WO 2007004515 | Jan 2007 | WO |
WO 2007024983 | Mar 2007 | WO |
WO 2007050439 | May 2007 | WO |
WO 2007090025 | Aug 2007 | WO |
WO 2007137115 | Nov 2007 | WO |
WO 2007137304 | Nov 2007 | WO |
WO 2008071898 | Jun 2008 | WO |
WO 2008102154 | Aug 2008 | WO |
WO 2008107902 | Sep 2008 | WO |
WO 2008131357 | Oct 2008 | WO |
WO 2009018409 | Feb 2009 | WO |
WO 2009046394 | Apr 2009 | WO |
WO 2009070780 | Jun 2009 | WO |
WO 2009073608 | Jun 2009 | WO |
WO 2010030850 | Mar 2010 | WO |
WO 2010096174 | Aug 2010 | WO |
WO 2011059785 | May 2011 | WO |
WO 2011089270 | Jul 2011 | WO |
Entry |
---|
Dietz, T. et al., Partially Implantable Vibrating Ossicular Prosthesis, Transducers'97, vol. 1, International Conference on Solid State Sensors and Actuators, (Jun. 16-19, 1997) pp. 433-436 (Abstract). |
“System 6 Aseptic Battety System,” Stryker (2006) pp. 1-2. |
Australian First Examination Report dated May 18, 2015 for Application No. 2011323284. |
Chinese Office Action dated Jan. 29, 2015 for Application No. 2011800640106. |
Chinese Office Action dated Jan. 29, 2015 for Application No. 2011800638159. |
Chinese Office Action dated Feb. 2, 2015 for Application No. 2011800534501. |
Chinese First Office Action dated Feb. 2, 2015 for App. No. CN 2011800641490. |
Chinese First Office Action dated Feb. 16, 2015 for App. No. CN 2011800638356. |
Chinese Office Action dated Feb. 16, 2015 for Application No. 2011800638286. |
Chinese First Office Action dated Feb. 28, 2015 for App No. CN 2011800641471. |
Chinese Office Action dated Mar. 4, 2015 for Application No. 201180063595.X. |
Chinese Office Action dated Mar. 30, 2015 for Application No. 2011800639823. |
Chinese Office Action dated Mar. 27, 2015 for Application No. 2011800638214. |
Chinese First Office Action dated Apr. 16, 2015 for App. No. CN 201180063919X. |
Chinese Office Action dated Apr. 20, 2015 for Application No. 2011800534342. |
Chinese Office Action dated Oct. 8, 2016 for Application No. 2011800534342. |
Chinese Search Report dated Oct. 8, 2016 for App. No. CN 2011800534342. |
Chinese Third Office Action dated Oct. 17, 2016 for App. No. CN 2011800534342. |
Chinese Office Action dated 17/17/16 for Application No. 2011800534342. |
Chinese Office Action dated Aug. 28, 2015 for Application No. 2011800640106. |
EP Communication dated Feb. 19, 2014 for Application No. EP 11781972.2. |
Indian Office Action, Examination Report, dated Mar. 28, 2018 for Application No. 4008/DELNP/2013, 6 pgs. |
Indian Office Action, Examination Report, dated Jun. 13, 2019 for Application No. 3973/DELNP/2013, 6 pgs. |
International Search Report and Written Opinion dated Jan. 26, 2012for Application No. PCT/US2011/059212. |
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059212. |
Communication from International Searching Authority dated Jan. 24, 2012 for Application No. PCT/US2011/059215. |
International Search Report dated Apr. 4, 2012 for Application No. PCT/US2011/059215. |
International Preliminary Report on Patentability dated May 8, 2013 for Application No. PCT/US2011/059215. |
International Search Report dated Feb. 13, 2012for Application No. PCT/US2011/059217. |
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059217. |
International Search Report dated Jun. 12, 2012 for Application No. PCT/US2011/059218. |
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCY/US2011/059218. |
International Search Report dated Jan. 26, 2012 for Application No. PCT/US11/059220. |
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059220. |
Communication from International Searching Authority dated Feb. 2, 2012for Application No. PCT/US2011/059222. |
International Search Report dated Apr. 18, 2012 for Application No. PCT/US2011/059222. |
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059222. |
International Search Report dated Feb. 1, 2012 for Application No. PCT/US11/059223. |
International Preliminary Report on Patentability dated Feb. 1, 2012 for Application No. PCT/US2011/059223. |
International Search Report dated Jan. 12, 2012 for Application No. PCT/US11/059226. |
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059226. |
International Search Report dated Mar. 15, 2012 for Application No. PCT/US2011/059338. |
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059338. |
International Search Report dated Feb. 7, 2012 for Application No. PCT/US2011/059351. |
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059351. |
International Search Report dated Feb. 2, 2012for Application No. PCT/US2011/059354. |
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059354. |
International Search Report dated May 29, 2012 for Application No. PCT/US11/059358. |
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059358. |
Communication from International Searching Authority dated Feb. 6, 2012for Application No. PCT/US2011/059362. |
International Search Report dated Aug. 22, 2012for Application No. PCT/US2011/059362. |
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059362. |
International Search Report dated Jun. 4, 2012 for Application No. PCT/US2011/059365. |
International Preliminary Report on Patentability dated May 8, 2013 for Application No. PCT/US2011/059365. |
International Search Report dated Feb. 23, 2012 for Application No. PCT/US2011/059371. |
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059371. |
Communication from International Searching Authority dated Feb. 2, 2012 for Application No. PCT/US2011/059378. |
International Search Report dated May 24, 2012 for Application No. PCT/US2011/059378. |
International Search Report and Written Opinion dated Feb. 2, 2012for Application No. PCT/US2011/059378. |
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059378. |
International Search Report dated Apr. 11, 2012 for Application No. PCT/US2011/059381. |
International Search Report and Written Opinion dated Jul. 6, 2012 for PCT/US2011/059381. |
International Preliminary Report on Patentability dated May 8, 2013 for Application No. PCT/US2011/059381. |
Japanese Office Action, Notification of Reasons for Refusal, dated Sep. 1, 2015 for Application No. 2013-537837. |
Japanese Office Action, Notification of Reasons for Refusal, dated Feb. 16, 2016 for Application No. 2013-537837. |
Japanese Office Action, Pretrial Examination Report, dated Aug. 2, 2016 for Application No. 2013-537837. |
Japanese Office Action, Notification of Reasons for Refusal, dated Sep. 1, 2015 for Application No. 2013-537866. |
Japanese Office Action, Notification of Reasons for Refusal, dated Jun. 28, 2016 for Application No. 2013-537866. |
Japanese Office Action, Examiner's Decision of Refusal, dated Sep. 13, 2016 for Application No. 2013-537869. |
Japanese Office Action, Notification of Reasons for Refusal, dated Oct. 6, 2015 for Application No. 2013-537869. |
Office Action Non-Final dated Aug. 6, 2013 for U.S. Appl. No. 13/151,471. |
Notice of Allowance dated Dec. 6, 2013 for U.S. Appl. No. 13/151,471. |
Office Action Non-Final dated Mar. 28, 2014 for U.S. Appl. No. 13/151,471. |
U.S. Office Action, Notice of Allowance, dated Aug. 19, 2014 for U.S. Appl. No. 13/151,471. |
U.S. Office Action, Notice of Allowance, dated Nov. 21, 2014 for U.S. Appl. No. 13/151,471. |
Restriction Requirement dated Dec. 11, 2012 for U.S. Appl. No. 13/151,481. |
Office Action Non-Final dated Feb. 15, 2013 for U.S. Appl. No. 13/151,481. |
Office Action Final dated Jun. 7, 2013 for U.S. Appl. No. 13/151,481. |
U.S. Office Action, Non-Final, dated Aug. 14, 2014 for U.S. Appl. No. 13/151,481. |
U.S. Office Action, Final, dated Apr. 1, 2015 for U.S. Appl. No. 13/151,481. |
U.S. Office Action, Notice of Allowance, dated Jun. 10, 2015 for U.S. Appl. No. 13/151,481. |
Restriction Requirement dated Jul. 5, 2013 for U.S. Appl. No. 13/151,488. |
U.S. Office Action, Non-Final, dated Nov. 7, 2014 for U.S. Appl. No. 13/151,488. |
U.S. Office Action, Final, dated Jul. 17, 2015 for U.S. Appl. No. 13/151,488. |
Office Action Non-Final dated Jun. 14, 2013 for U.S. Appl. No. 13/151,498. |
Office Action Final dated Nov. 21, 2013 for U.S. Appl. No. 13/151,498. |
Office Action Non-Final dated Mar. 18, 2014 for U.S. Appl. No. 13/151,498. |
U.S. Office Action, Notice of Allowance, dated Aug. 6, 2014 for U.S. Appl. No. 13/151,498. |
U.S. Office Action, Notice of Allowance, dated Nov. 21, 2014 for U.S. Appl. No. 13/151,498. |
U.S. Office Action, Non-Final, dated Jun. 18, 2014 for U.S. Appl. No. 13/151,503. |
U.S. Office Action, Non-Final, dated Nov. 6, 2014 for U.S. Appl. No. 13/151,503. |
U.S. Office Action, Final, dated Jun. 8, 2015 for U.S. Appl. No. 13/151,503. |
U.S. Office Action, Non-Final, dated Oct. 2, 2015 for U.S. Appl. No. 13/151,503. |
U.S. Office Action, Final, dated Mar. 9, 2016 for U.S. Appl. No. 13/151,503. |
U.S. Office Action, Notice of Allowance, dated Jul. 27, 2016 for U.S. Appl. No. 13/151,503. |
U.S. Office Action, Notice of Allowance, dated Nov. 2, 2016 for U.S. Appl. No. 13/151,503. |
Restriction Requirement dated Mar. 13, 2013 for U.S. Appl. No. 13/151,509. |
Restriction Requirement dated Jun. 24, 2013 for U.S. Appl. No. 13/151,509. |
Office Action Non-Final dated Sep. 26, 2013 for U.S. Appl. No. 13/151,509. |
Office Action Final dated Jan. 29, 2014 for U.S. Appl. No. 13/151,509. |
Office Action Non-Final dated Jul. 9, 2014 for U.S. Appl. No. 13/151,509. |
U.S. Office Action, Notice of Allowance, dated Oct. 28, 2014 for U.S. Appl. No. 13/151,509. |
U.S. Office Action, Notice of Allowance, dated Feb. 25, 2015 for U.S. Appl. No. 13/151,509. |
Restriction Requirement dated Jun. 11, 2014 for U.S. Appl. No. 13/151,512. |
U.S. Office Action, Notice of Allowance, dated Oct. 29, 2014 for U.S. Appl. No. 13/151,512. |
U.S. Office Action, Notice of Allowance, dated Feb. 17, 2015 for U.S. Appl. No. 13/151,512. |
U.S. Office Action, Restriction Requirement, dated Jul. 11, 2014 for U.S. Appl. No. 13/269,870. |
U.S. Office Action, Non-Final, dated Jan. 5, 2015 for U.S. Appl. No. 13/269,870. |
Restriction Requirement dated Feb. 28, 2013 for U.S. Appl. No. 13/270,667. |
Office Action Non-Final dated Apr. 26, 2013 for U.S. Appl. No. 13/270,667. |
Office Action Final dated Oct. 25, 2013 for U.S. Appl. No. 13/270,667. |
U.S. Office Action, Non-Final, dated Jul. 29, 2014 for U.S. Appl. No. 13/270,667. |
U.S. Office Action, Notice of Allowance, dated Dec. 17, 2014 for U.S. Appl. No. 13/270,667. |
U.S. Office Action, Restriction Requirement, dated Jul. 9, 2014 for U.S. Appl. No. 13/270,684. |
U.S. Office Action, Non-Final, dated Oct. 9, 2014 for U.S. Appl. No. 13/270,684. |
U.S. Office Action, Final, dated Mar. 7, 2015 for U.S. Appl. No. 13/270,684. |
U.S. Office Action, Notice of Allowance, dated Jul. 28, 2015 for U.S. Appl. No. 13/270,684. |
U.S. Office Action, Restriction Requirement, dated Sep. 11, 2014 for U.S. Appl. No. 13/270,701. |
U.S. Office Action, Non-Final, dated Dec. 16, 2014 for U.S. Appl. No. 13/270,701. |
U.S. Office Action, Final, dated Jun. 17, 2015 for U.S. Appl. No. 13/270,701. |
Office Action Non-Final dated Nov. 21, 2013 for U.S. Appl. No. 13/271,352. |
U.S. Office Action, Restriction Requirement, dated Sep. 25, 2014 for U.S. Appl. No. 13/271,352. |
U.S. Office Action, Non-Final, dated Mar. 26, 2015 for U.S. Appl. No. 13/271,352. |
U.S. Office Action, Final, dated Jul. 15, 2015 for U.S. Appl. No. 13/271,352. |
U.S. Office Action, Restriction Requirement, dated Feb. 25, 2015 for U.S. Appl. No. 13/271,364. |
U.S. Office Action, Non-Final, dated Jul. 14, 2015 for U.S. Appl. No. 13/271,364. |
U.S. Office Action, Restriction Requirement, dated Oct. 2, 2013 for U.S. Appl. No. 13/274,480. |
Office Action Non-Final dated Feb. 14, 2014 for U.S. Appl. No. 13/274,480. |
U.S. Office Action, Final, dated Jul. 17, 2014 for U.S. Appl. No. 13/274,480. |
U.S. Office Action, Non-Final, dated May 1, 2015 for U.S. Appl. No. 13/274,480. |
Restriction Requirement dated Dec. 9, 2013 for U.S. Appl. No. 13/274,496. |
Office Action Non-Final dated Feb. 6, 2014 for U.S. Appl. No. 13/274,496. |
Office Action Final dated May 15, 2014 for U.S. Appl. No. 13/274,496. |
U.S. Office Action, Final, dated Aug. 22, 2014 for U.S. Appl. No. 13/274,496. |
U.S. Office Action, Non-Final, dated Apr. 2, 2015 for U.S. Appl. No. 13/274,496. |
Restriction Requirement dated Mar. 28, 2014 for U.S. Appl. No. 13/274,507. |
Office Action Non-Final dated Jun. 19, 2014 for U.S. Appl. No. 13/274,507. |
U.S. Office Action, Non-Final, dated Jul. 22, 2015 for U.S. Appl. No. 13/274,507. |
Office Action Non-Final dated Dec. 21, 2012 for U.S. Appl. No. 13/274,516. |
Office Action Final dated Aug. 16, 2013 for U.S. Appl. No. 13/274,516. |
Office Action Non-Final dated Dec. 6, 2013 for U.S. Appl. No. 13/274,516. |
U.S. Office Action, Final, dated Jun. 12, 2014 for U.S. Appl. No. 13/274,516. |
U.S. Office Action, Non-Final, dated Oct. 8, 2014 for U.S. Appl. No. 13/274,516. |
U.S. Office Action, Final, dated May 8, 2015 for U.S. Appl. No. 13/274,516. |
Restriction Requirement dated Feb. 25, 2013 for U.S. Appl. No. 13/274,540. |
Office Action Non-Final dated Apr. 30, 2013 for U.S. Appl. No. 13/274,540. |
Office Action Final dated Oct. 25, 2013 for U.S. Appl. No. 13/274,540. |
U.S. Office Action. Non-Final, dated Aug. 26, 2014 for U.S. Appl. No. 13/274,540. |
U.S. Office Action, Notice of Allowance, dated Jan. 21, 2015 for U.S. Appl. No. 13/274,540. |
Office Action Non-Final dated Apr. 1, 2013 for U.S. Appl. No. 13/274,805. |
Office Action Final dated Sep. 12, 2013 for U.S. Appl. No. 13/274,805. |
U.S. Office Action, Non-Final, dated Aug. 14, 2014 for U.S. Appl. No. 13/274,805. |
U.S. Office Action, Notice of Allowance, dated Nov. 28, 2014 for U.S. Appl. No. 13/274,805. |
U.S. Office Action, Notice of Allowance, dated Jan. 21, 2015 for U.S. Appl. No. 13/274,805. |
Restriction Requirement dated Apr. 29, 2013 for U.S. Appl. No. 13/274,830. |
Office Action Non-Final dated Jun. 14, 2013 for U.S. Appl. No. 13/274,830. |
Office Action Final dated Nov. 26, 2013 for U.S. Appl. No. 13/274,830. |
U.S. Office Action, Non-Final, dated Oct. 22, 2014 for U.S. Appl. No. 13/274,830. |
U.S. Office Action, Notice of Allowance, dated Mar. 23, 2015 for U.S. Appl. No. 13/274,830. |
U.S. Office Action, Notice of Allowance, dated Jul. 9, 2015 for U.S. Appl. No. 13/274,830. |
Restriction Requirement dated Apr. 4, 2013 for U.S. Appl. No. 13/275,495. |
Office Action Non-Final dated May 31, 2013 for U.S. Appl. No. 13/275,495. |
Office Action Final dated Dec. 5, 2013 for U.S. Appl. No. 13/275,495. |
U.S. Office Action, Non-Final, dated Feb. 25, 2015 for U.S. Appl. No. 13/275,495. |
U.S. Office Action, Final, dated May 27, 2015 for U.S. Appl. No. 13/275,495. |
U.S. Office Action, Non-Final, dated Jun. 6, 2016 for U.S. Appl. No. 13/275,495. |
U.S. Office Action, Final, dated Dec. 21, 2016 for U.S. Appl. No. 13/275,495. |
Office Action Non-Final dated Jan. 6, 2014 for U.S. Appl. No. 13/275,514. |
U.S. Office Action, Non-Final, dated Sep. 9, 2014 for U.S. Appl. No. 13/275,514. |
U.S. Office Action, Non-Final, dated May 21, 2015 for U.S. Appl. No. 13/275,514. |
U.S. Office Action, Final, dated Sep. 11, 2015 for U.S. Appl. No. 13/275,514. |
U.S. Office Action, Notice of Allowance, dated Nov. 25, 2015 for U.S. Appl. No. 13/275,514. |
U.S. Office Action, Notice of Allowance, dated Mar. 2, 2016 for U.S. Appl. No. 13/275,514. |
Office Action Non-Final dated May 17, 2013 for U.S. Appl. No. 13/275,547. |
Office Action Final dated Feb. 28, 2014 for U.S. Appl. No. 13/275,547. |
U.S. Office Action, Non-Final, dated Aug. 20, 2014 for U.S. Appl. No. 13/275,547. |
U.S. Office Action, Final, dated Mar. 10, 2015 for U.S. Appl. No. 13/275,547. |
U.S. Office Action, Non-Final, dated Aug. 28, 2015 for U.S. Appl. No. 13/275,547. |
U.S. Office Action, Final, dated May 6, 2016 for U.S. Appl. No. 13/275,547. |
Office Action Non-Final dated Feb. 1, 2013 for U.S. Appl. No. 13/275,563. |
Office Action Final dated Aug. 29, 2013 for U.S. Appl. No. 13/275,563. |
U.S. Office Action, Non-Final, dated Oct. 23, 2014 for U.S. Appl. No. 13/275,563. |
U.S. Office Action, Non-Final, dated May 28, 2015 for U.S. Appl. No. 13/275,563. |
Restriction Requirement dated Feb. 6, 2013 for U.S. Appl. No. 13/276,660. |
Office Action Non-Final dated Jun. 3, 2013 for U.S. Appl. No. 13/246,660. |
U.S. Office Action, Restriction Requirement, dated Jul. 9, 2014 for U.S. Appl. No. 13/276,660. |
U.S. Office Action, Notice of Allowance, dated Jun. 17, 2015 for U.S. Appl. No. 13/276,660. |
Office Action Non-Final dated Dec. 21, 2012 for U.S. Appl. No. 13/276,673. |
Office Action Non-Final dated Aug. 19, 2013 for U.S. Appl. No. 13/276,673. |
Office Action Final dated Mar. 21, 2014 for U.S. Appl. No. 13/276,673. |
U.S. Office Action, Non-Final, dated Aug. 14, 2014 for U.S. Appl. No. 13/276,673. |
U.S. Office Action, Final, dated Mar. 13, 2015 for U.S. Appl. No. 13/276,673. |
Restriction Requirement dated Feb. 6, 2013 for U.S. Appl. No. 13/276,687. |
Office Action Non-Final dated Jun. 12, 2013 for U.S. Appl. No. 13/276,687. |
Notice of Allowance dated Nov. 12, 2013 for U.S. Appl. No. 13/276,687. |
Notice of Allowance dated Jun. 2, 2014 for U.S. Appl. No. 13/276,687. |
U.S. Office Action, Notice of Allowance, dated Sep. 12, 2014 for U.S. Appl. No. 13/276,687. |
U.S. Office Action, Notice of Allowance, dated Dec. 23, 2014 for U.S. Appl. No. 13/276,687. |
Restriction Requirement dated Feb. 21, 2013 for U.S. Appl. No. 13/276,707. |
Office Action Non-Final dated May 6, 2013 for U.S. Appl. No. 13/276,707. |
Office Action Final dated Sep. 27, 2013 for U.S. Appl. No. 13/276,707. |
U.S. Office Action, Non-Final, dated Jan. 29, 2015 for U.S. Appl. No. 13/276,707. |
U.S. Office Action, Non-Final, dated Jul. 16, 2015 for U.S. Appl. No. 13/276,707. |
Restriction Requirement dated Feb. 6, 2013 for U.S. Appl. No. 13/276,725. |
U.S. Office Action, Non-Final, dated Aug. 20, 2014 for U.S. Appl. No. 13/276,725. |
U.S. Office Action, Notice of Allowance, dated Mar. 13, 2015 for U.S. Appl. No. 13/276,725. |
Restriction Requirement dated Dec. 21, 2012 for U.S. Appl. No. 13/276,745. |
Office Action Non-Final dated Apr. 30, 2013 for U.S. Appl. No. 13/276,745. |
Office Action Final dated Nov. 8, 2013 for U.S. Appl. No. 13/276,745. |
Office Action Non-Final dated Feb. 28, 2014 for U.S. Appl. No. 13/276,745. |
U.S. Office Action, Notice of Allowance, dated Oct. 7, 2014 for U.S. Appl. No. 13/276,745. |
U.S. Office Action, Notice of Allowance, dated Dec. 19, 2014 for U.S. Appl. No. 13/276,745. |
U.S. Office Action, Restriction Requirement, dated Sep. 24, 2014 for U.S. Appl. No. 13/277,328. |
U.S. Office Action, Non-Final, dated Dec. 8, 2014 for U.S. Appl. No. 13/277,328. |
U.S. Office Action, Final, dated Mar. 24, 2015 for U.S. Appl. No. 13/277,328. |
U.S. Office Action, Notice of Allowance, dated Jun. 1, 2015 for U.S. Appl. No. 13/277,328. |
Indian Office Action, Examination Report, dated Oct. 22, 2019 for Application No. 3968/DELNP/2013, 7 pgs. |
Indian Office Action, Examination Report, dated Nov. 30, 2019 for Application No. 4013/DELNP/2013, 6pgs. |
Indian Office Action, Examination Report, dated Jul. 12, 2019 for Application No. 3960/DELNP/2013, 8 pgs. |
U.S. Appl. No. 16/549,798, filed Aug. 23, 2019, by Houser et al., entitled: “Surgical Instrument With Charging Station and Wireless Communication.” |
Number | Date | Country | |
---|---|---|---|
20200229863 A1 | Jul 2020 | US |
Number | Date | Country | |
---|---|---|---|
61487846 | May 2011 | US | |
61410603 | Nov 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15212423 | Jul 2016 | US |
Child | 16779748 | US | |
Parent | 13151503 | Jun 2011 | US |
Child | 15212423 | US |